Literature DB >> 21344193

[Vaccination in adults].

D M Kieninger-Baum1, F Zepp.   

Abstract

The vaccination programme for adults in Germany is based on the comprehensive immunization acquired during childhood and adolescence. The goal of these vaccinations given at regular intervals is to achieve effective immunization coverage lasting into old age. The public health authorities in Germany recommend, according to the Standing Vaccination Commission (STIKO) standards, that adults should receive at least a decennial booster vaccination against diphtheria and tetanus as well as a pertussis booster if the last pertussis vaccine was administered more than 10 years earlier. Individuals above the age of 60 additionally benefit from vaccinations against pneumococcal diseases and annual vaccinations against seasonal influenza. In special life situations, e.g. during pregnancy, vaccination against influenza is also recommended for younger people. The current amendments to the recommendations of the STIKO are aimed at definitive control of measles and eradication of rubella embryopathy. A periodic check-up of the individual vaccination status, and if appropriate completion of missing vaccinations is an important duty of every practising physician. Supporting the creation of herd immunity contributes to the protection of individuals as well as the whole population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21344193     DOI: 10.1007/s00108-010-2677-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  40 in total

Review 1.  Duration of immunity against pertussis after natural infection or vaccination.

Authors:  Aaron M Wendelboe; Annelies Van Rie; Stefania Salmaso; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

2.  Large measles outbreak at a German public school, 2006.

Authors:  Ole Wichmann; Wiebke Hellenbrand; Daniel Sagebiel; Sabine Santibanez; Gabriele Ahlemeyer; Georg Vogt; Anette Siedler; Ulrich van Treeck
Journal:  Pediatr Infect Dis J       Date:  2007-09       Impact factor: 2.129

Review 3.  Cytokine network at the feto-maternal interface.

Authors:  S Saito
Journal:  J Reprod Immunol       Date:  2000-07       Impact factor: 4.054

4.  [Immunisation coverage in the adult workforce 2003. Utilisation of routine occupational health checks to ascertain vaccination coverage in employees].

Authors:  H-M Bader; P Egler
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2004-12       Impact factor: 1.513

5.  Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants.

Authors:  Steven B Black; Henry R Shinefield; Eric K France; Bruce H Fireman; Sharon T Platt; David Shay
Journal:  Am J Perinatol       Date:  2004-08       Impact factor: 1.862

6.  Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.

Authors:  C E Johnson; M L Kumar; J K Whitwell; B O Staehle; L P Rome; C Dinakar; W Hurni; D R Nalin
Journal:  Pediatr Infect Dis J       Date:  1996-08       Impact factor: 2.129

7.  Prospective multinational study of pertussis infection in hospitalized infants and their household contacts.

Authors:  Frank Kowalzik; Arnaldo Prata Barbosa; Vera Regina Fernandes; Paulo Roberto Carvalho; Maria Luisa Avila-Aguero; Daniel Y T Goh; Anne Goh; Jesus Garcia de Miguel; Fernando Moraga; Joan Roca; Magda Campins; Ming Huang; Jorge Quian; Nicole Riley; Dominique Beck; Thomas Verstraeten
Journal:  Pediatr Infect Dis J       Date:  2007-03       Impact factor: 2.129

8.  Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial.

Authors:  Jean Beytout; Odile Launay; Nicole Guiso; Anne Fiquet; Martine Baudin; Patrick Richard; Charles Baptiste; Benoît Soubeyrand
Journal:  Hum Vaccin       Date:  2009-05-01

9.  Protection of infants from infection with influenza A virus by transplacentally acquired antibody.

Authors:  J M Puck; W P Glezen; A L Frank; H R Six
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

10.  Infant pertussis: who was the source?

Authors:  Kristine M Bisgard; F Brian Pascual; Kristen R Ehresmann; Claudia A Miller; Christy Cianfrini; Charles E Jennings; Catherine A Rebmann; Julie Gabel; Stephanie L Schauer; Susan M Lett
Journal:  Pediatr Infect Dis J       Date:  2004-11       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.